Functionally, the PPARδ/NKD1/MYC signaling pathway increased colon cancer cells’ proliferation, migration and angiogenesis capabilities in vitro and in vivo, suggesting that NKD1 could serve as a potential therapeutic target for colon cancer diagnosis and treatment. Here, NKD1 is linked to malignant colon neoplasm.